Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein

Tracy Criswell, Dmitry Klokov, Meghan Beman, J. P. Lavik, David A. Boothman

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

The clusterin (CLU) protein has been reported to have both cytoprotective and cytotoxic activities. Previous data from our lab suggest that the secretory form of CLU (sCLU) is cytoprotective and induced after very low, nontoxic doses of ionizing radiation (IR: > 0.02 Gy), while a nuclear form is cytotoxic.1 Cells must presumably suppress sCLU to stimulate cell death, however, factors regulating the stress-inducible expression of sCLU have not been elucidated. Here we demonstrate that p53 can suppress sCLU induction responses. A variety of cytotoxic agents stimulated sCLU expression and DNA damage was sufficient, but not necessary for induction. IR-stimulated CLU promoter activity, with concomitant increases in CLU mRNA and protein, showed that CLU induction was delayed with maximal expression observed 48-96 h post-treatment. Expression of the human papillomavirus E6 protein in MCF-7 breast or RKO colon cancer cells enhanced basal CLU levels. Isogenically matched HCT116 colon cancer cell lines that differed only in p53 or p21 status, confirmed a role for p53 in the transcriptional repression of sCLU. Loss of functional p53 in HCT116:p53 -/- cells augmented CLU de novo synthesis after IR exposure. Repression of cytoprotective sCLU protein levels by p53 may be important for the cascade of p53-mediated events leading to cell death after IR or other cytotoxic agent exposure.

Original languageEnglish (US)
Pages (from-to)372-380
Number of pages9
JournalCancer Biology and Therapy
Volume2
Issue number4
DOIs
StatePublished - Jul 2003

Fingerprint

Clusterin
Tumor Suppressor Protein p53
Cytotoxins
Colonic Neoplasms
Proteins
Cell Death
HCT116 Cells
Ionizing Radiation
DNA Damage
Breast
Cell Line
Messenger RNA

Keywords

  • Clusterin
  • Ionizing radiation
  • p53

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Molecular Medicine
  • Pharmacology

Cite this

Criswell, T., Klokov, D., Beman, M., Lavik, J. P., & Boothman, D. A. (2003). Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein. Cancer Biology and Therapy, 2(4), 372-380. https://doi.org/10.4161/cbt.2.4.430

Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein. / Criswell, Tracy; Klokov, Dmitry; Beman, Meghan; Lavik, J. P.; Boothman, David A.

In: Cancer Biology and Therapy, Vol. 2, No. 4, 07.2003, p. 372-380.

Research output: Contribution to journalArticle

Criswell, T, Klokov, D, Beman, M, Lavik, JP & Boothman, DA 2003, 'Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein', Cancer Biology and Therapy, vol. 2, no. 4, pp. 372-380. https://doi.org/10.4161/cbt.2.4.430
Criswell, Tracy ; Klokov, Dmitry ; Beman, Meghan ; Lavik, J. P. ; Boothman, David A. / Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein. In: Cancer Biology and Therapy. 2003 ; Vol. 2, No. 4. pp. 372-380.
@article{f48a033ee57a48628171152c20030386,
title = "Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein",
abstract = "The clusterin (CLU) protein has been reported to have both cytoprotective and cytotoxic activities. Previous data from our lab suggest that the secretory form of CLU (sCLU) is cytoprotective and induced after very low, nontoxic doses of ionizing radiation (IR: > 0.02 Gy), while a nuclear form is cytotoxic.1 Cells must presumably suppress sCLU to stimulate cell death, however, factors regulating the stress-inducible expression of sCLU have not been elucidated. Here we demonstrate that p53 can suppress sCLU induction responses. A variety of cytotoxic agents stimulated sCLU expression and DNA damage was sufficient, but not necessary for induction. IR-stimulated CLU promoter activity, with concomitant increases in CLU mRNA and protein, showed that CLU induction was delayed with maximal expression observed 48-96 h post-treatment. Expression of the human papillomavirus E6 protein in MCF-7 breast or RKO colon cancer cells enhanced basal CLU levels. Isogenically matched HCT116 colon cancer cell lines that differed only in p53 or p21 status, confirmed a role for p53 in the transcriptional repression of sCLU. Loss of functional p53 in HCT116:p53 -/- cells augmented CLU de novo synthesis after IR exposure. Repression of cytoprotective sCLU protein levels by p53 may be important for the cascade of p53-mediated events leading to cell death after IR or other cytotoxic agent exposure.",
keywords = "Clusterin, Ionizing radiation, p53",
author = "Tracy Criswell and Dmitry Klokov and Meghan Beman and Lavik, {J. P.} and Boothman, {David A.}",
year = "2003",
month = "7",
doi = "10.4161/cbt.2.4.430",
language = "English (US)",
volume = "2",
pages = "372--380",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "4",

}

TY - JOUR

T1 - Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein

AU - Criswell, Tracy

AU - Klokov, Dmitry

AU - Beman, Meghan

AU - Lavik, J. P.

AU - Boothman, David A.

PY - 2003/7

Y1 - 2003/7

N2 - The clusterin (CLU) protein has been reported to have both cytoprotective and cytotoxic activities. Previous data from our lab suggest that the secretory form of CLU (sCLU) is cytoprotective and induced after very low, nontoxic doses of ionizing radiation (IR: > 0.02 Gy), while a nuclear form is cytotoxic.1 Cells must presumably suppress sCLU to stimulate cell death, however, factors regulating the stress-inducible expression of sCLU have not been elucidated. Here we demonstrate that p53 can suppress sCLU induction responses. A variety of cytotoxic agents stimulated sCLU expression and DNA damage was sufficient, but not necessary for induction. IR-stimulated CLU promoter activity, with concomitant increases in CLU mRNA and protein, showed that CLU induction was delayed with maximal expression observed 48-96 h post-treatment. Expression of the human papillomavirus E6 protein in MCF-7 breast or RKO colon cancer cells enhanced basal CLU levels. Isogenically matched HCT116 colon cancer cell lines that differed only in p53 or p21 status, confirmed a role for p53 in the transcriptional repression of sCLU. Loss of functional p53 in HCT116:p53 -/- cells augmented CLU de novo synthesis after IR exposure. Repression of cytoprotective sCLU protein levels by p53 may be important for the cascade of p53-mediated events leading to cell death after IR or other cytotoxic agent exposure.

AB - The clusterin (CLU) protein has been reported to have both cytoprotective and cytotoxic activities. Previous data from our lab suggest that the secretory form of CLU (sCLU) is cytoprotective and induced after very low, nontoxic doses of ionizing radiation (IR: > 0.02 Gy), while a nuclear form is cytotoxic.1 Cells must presumably suppress sCLU to stimulate cell death, however, factors regulating the stress-inducible expression of sCLU have not been elucidated. Here we demonstrate that p53 can suppress sCLU induction responses. A variety of cytotoxic agents stimulated sCLU expression and DNA damage was sufficient, but not necessary for induction. IR-stimulated CLU promoter activity, with concomitant increases in CLU mRNA and protein, showed that CLU induction was delayed with maximal expression observed 48-96 h post-treatment. Expression of the human papillomavirus E6 protein in MCF-7 breast or RKO colon cancer cells enhanced basal CLU levels. Isogenically matched HCT116 colon cancer cell lines that differed only in p53 or p21 status, confirmed a role for p53 in the transcriptional repression of sCLU. Loss of functional p53 in HCT116:p53 -/- cells augmented CLU de novo synthesis after IR exposure. Repression of cytoprotective sCLU protein levels by p53 may be important for the cascade of p53-mediated events leading to cell death after IR or other cytotoxic agent exposure.

KW - Clusterin

KW - Ionizing radiation

KW - p53

UR - http://www.scopus.com/inward/record.url?scp=2342566706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342566706&partnerID=8YFLogxK

U2 - 10.4161/cbt.2.4.430

DO - 10.4161/cbt.2.4.430

M3 - Article

C2 - 14508108

AN - SCOPUS:2342566706

VL - 2

SP - 372

EP - 380

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 4

ER -